EMA Seeks Feedback On New Platform To Bridge Gaps In Regulatory Science Research

The European Medicines Agency has given stakeholders until 18 December to give their opinion on its proposed platform for addressing gaps and research needs in regulatory science.

(Shutterstock)

The European Medicines Agency is proposing to create a platform to identify “new and recurring issues in medicines development.”

More from EMA

More from Pathways & Standards